col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


59 Results       Page 1

 [1] 
Elsevier: Gene
  original article Date Title Authors   All Authors
1 [GO] 2024―Nov―15 Characterization of novel ACE2 mRNA transcripts: The potential role of alternative splicing in SARS-CoV-2 infection Panagiotis G. Adamopoulos, Natalia Bartzoka, Panagiotis Tsiakanikas, Andreas Scorilas
2 [GO] 2024―Oct―23 Optimal control analysis on the spread of COVID-19: Impact of contact transmission and environmental contamination Sunil Singh Negi, Nitin Sharma, Anupam Priyadarshi
3 [GO] 2024―Oct―20 Insights into disease resilience and longevity: Hints from COVID-19 recovered nonagenarians and centenarians Mateus V. de Castro, Cristina Sábato, Raíssa M. Dandalo-Girardi, Monize V.R. Silva, Luiz P. Dell’Aquila, Álvaro Razuk-Filho, et al. (+3)
4 [GO] 2024―Sep―30 Mathematical model for understanding the relationship between diabetes and novel coronavirus Preety Kumari, Harendra Pal Singh, Swarn Singh
5 [GO] 2024―Aug―06 Modelling on COVID-19 control with double and booster-dose vaccination Preety Kalra, Shoket Ali, Samuel Ocen
6 [GO] 2024―May―31 Based on epidemiological parameter data, probe into a stochastically perturbed dominant variant of the COVID-19 pandemic model S.P. Rajasekar, R. Ramesh, Yassine Sabbar
7 [GO] 2024―May―22 Dual-strain dynamics of COVID-19 variants in India: Modeling, analysis, and implications for pandemic control Sunil Singh Negi, Nitin Sharma, Haci Mehmet Baskonus
8 [GO] 2024―May―16 Delving a stochastic SEQAIJR COVID-19 model with hexa delayed and copious control strategies M. Pitchaimani, U. Aswini
9 [GO] 2024―May―14 An entropy-based study on the mutational landscape of SARS-CoV-2 in USA: comparing different variants and revealing co-mutational behavior of proteins Daniele Santoni
10 [GO] 2024―May―13 Long-term effect of SARS-CoV-2 variant : Challenging issues and controlling strategies M. Pitchaimani, U. Aswini
11 [GO] 2024―May―10 Repurposing of antimycobacterium drugs for COVID-19 treatment by targeting SARS CoV-2 main protease: An in-silico perspective Ayon Chakraborty, Rajesh Ghosh, Saswati Soumya Mohapatra, Subhashree Barik, Ashis Biswas, Snehasis Chowdhuri
12 [GO] 2024―Apr―24 Whole genome analysis reveals unique traits of SARS-CoV-2 in pediatric patients Sara Chandy, Hithesh Kumar, Sara Pearl, Soumya Basu, Gurumoorthy M, Janani Sankar, et al. (+3)
13 [GO] 2024―Apr―03 Dynamic analysis of SARS-CoV-2 evolution based on different countries Binghan Xiao, Linhuan Wu, Qinlan Sun, Chang Shu, Songnian Hu
14 [GO] 2024―Apr―02 A positive selection at binding site 501 in the B.1 lineage might have triggered the highly infectious sub-lineages of SARS-CoV-2 Basant K. Tiwary
15 [GO] 2024―Mar―14 SARS-CoV-2 and UPS with potentials for therapeutic interventions Jannatul Ferdoush, Rizwaan Abdul Kadir, Selin Simay Kaplanoglu, Morgan Osborn
16 [GO] 2024―Mar―12 Nigella sativa, Anthemis hyaline and Citrus sinensis extracts reduce SARS-CoV-2 replication by fluctuating Rho GTPase, PI3K-AKT, and MAPK/ERK pathways in HeLa-CEACAM1a cells Mehmet Bostancıklıoğlu, Mehri İğci, Mustafa Ulaşlı
17 [GO] 2024―Mar―07 Chaos theory in the understanding of COVID-19 pandemic dynamics Arianna Calistri, Pier Francesco Roggero, Giorgio Palé
18 [GO] 2024―Feb―28 Geometric analysis of SARS-CoV-2 variants Mengcen Guan, Nan Sun, Stephen S.-T. Yau
19 [GO] 2024―Feb―03 Single-Nucleotide Polymorphisms Related to Vitamin D Metabolism and Severity or Mortality of COVID-19: A Systematic Review and Meta-analysis Carla Regina da Silva Correa da Ronda, Marília Berlofa Visacri, Júlia Tiemi Siguemoto, Carolini Motta Neri, Micaela Crispim Lopo de Abreu, Aline de Souza Nicoletti, et al. (+5)
20 [GO] 2023―Sep―01 Bioinformatics analysis of carotid vulnerable plaques associated with the SARS-CoV-2 pattern Tao Jiang, Jiaming Huang, Shupeng Li, Qiushi Xu, Tianding Zhang, Xianwei Wang, Dong Chen
21 [GO] 2023―Jul―08 Targeting cytokine storm as the potential anti-viral therapy: Implications in regulating SARS-CoV-2 pathogenicity Subashish Maity, Ayantika Santra, Ananda Vardhan Hebbani, Swetha Pulakuntla, Ankita Chatterjee, Kameswara Rao Badri, Vaddi Damodara Reddy
22 [GO] 2023―Mar―02 INFLAMMASOME GENES POLYMORPHISMS ARE ASSOCIATED WITH PROGRESSION TO MECHANICAL VENTILATION AND DEATH IN A COHORT OF HOSPITALIZED COVID-19 PATIENTS IN A REFERENCE HOSPITAL IN RIO DE JANEIRO, BRAZIL Milena Neira-Goulart, Nathalia Beatriz Ramos de Sá, Marcelo Ribeiro-Alves, Hugo Perazzo, Kim Mattos Geraldo, Maria Pia Diniz Ribeiro, et al. (+9)
23 [GO] 2023―Feb―02 Emerging role of microRNAs and long non-coding RNAs in COVID-19 with implications to therapeutics Kaifee Arman, Zeinab Dalloul, Esra Bozgeyik
24 [GO] 2022―Dec―25 Loss of furin site enhances SARS-CoV-2 spike protein pseudovirus infection Zeng Wang, Kunhong Zhong, Guoqing Wang, Qizhong Lu, Hexian Li, Zhiguo Wu, et al. (+7)
25 [GO] 2022―Dec―05 In silico analysis of genomic landscape of SARS-CoV-2 and its variant of concerns (Delta and Omicron) reveals changes in the coding potential of miRNAs and their target genes Sandeep Saini, Savi Khurana, Dikshant Saini, Saru Rajput, Chander Jyoti Thakur, Jeevisha Singh, et al. (+4)
26 [GO] 2022―Nov―13 Transcriptional profiles and common genes link lung cancer with the development and severity of COVID-19 SS. Cury, JS. Oliveira, CAO. Biagi-Júnior, Silva Jr WA, PP. Reis, O. Cabral-Marques, et al. (+3)
27 [GO] 2022―Nov―04 Geographical distribution of host's specific SARS-CoV-2 mutations in the early phase of the COVID-19 pandemic Mohammad Khalid, David Murphy, Maryam Shoai, Jonahunnatha Nesson George-William, Yousef Al-ebini
28 [GO] 2022―Aug―17 Systematic review and meta-analysis of human genetic variants contributing to COVID-19 susceptibility and severity Kajal Gupta, Gaganpreet Kaur, Tejal Pathak, Indranil Banerjee
29 [GO] 2022―Jul―27 Analysis of the mutation dynamics of sars-cov-2 genome in the samples from georgia state of the united states Waqas Ahmad, Sarfraz Ahmad, Riyaz Basha
30 [GO] 2022―Jun―28 Functional associations between polymorphic regions of the human 3′IgH locus and COVID-19 disease Mattia Colucci, Domenico Frezza, Giovanni Gambassi, Francesco De Vito, Angela Iaquinta, Maria Grazia Massaro, et al. (+7)
31 [GO] 2022―Jun―18 Roles of Mitochondrial DNA in Dynamics of the Immune Response to COVID-19 Ata Mahmoodpoor, Sarvin Sanaie, Zoherh Ostadi, Maqsoud Eskandari, Nazila Behrouzi, Roqayyeh Asghari, et al. (+3)
32 [GO] 2022―Jun―14 The Association of COVID-19 Severity and Susceptibility and Genetic Risk Factors: A Systematic Review of the literature Angela Ishak, Meghana Mehendale, Mousa Mahmoud AlRawashdeh, Cristina Sestacovschi, Medha Sharath, Krunal Pandav, Sima Marzban
33 [GO] 2022―Jun―11 Variation in synonymous nucleotide composition among genomes of sarbecoviruses and consequences for the origin of COVID-19 Alexandre Hassanin
34 [GO] 2022―Jun―06 Immunoregulation of Ghrelin in neurocognitive sequelae associated with COVID-19: an in silico investigation Cristina Russo, Giovanna Morello, Giuliana Mannino, Antonella Russo, Lucia Malaguarnera
35 [GO] 2022―May―13 Human T-lymphotropic virus type 1 and novel Coronavirus Disease 2019; More complex than just a simple coinfection Samaneh Sajjadi, Sepideh Hejazi, Sahar Ravanshad, Reza Jafarzadeh Esfehani
36 [GO] 2022―Mar―22 Mind the feline coronavirus: Comparison with SARS-CoV-2 Yong-yu Gao, Xiang-yu Liang, Qian Wang, Shuang Zhang, Han Zhao, Kai Wang, et al. (+3)
37 [GO] 2022―Mar―04 Role of Genomics in combating COVID-19 pandemic K.A. Saravanan, Manjit Panigrahi, Harshit Kumar, Divya Rajawat, Sonali Sonejita Nayak, Bharat Bhushan, Triveni Dutt
38 [GO] 2022―Jan―06 Palindromic Target Site Identification in SARS-CoV-2, MERS-CoV and SARS-CoV-1 by Adopting CRISPR-Cas Technique Nimisha Ghosh, Indrajit Saha, Nikhil Sharma
39 [GO] 2022―Jan―04 From Delta to Omicron: S1-RBD/S2 mutation/deletion equilibrium in SARS-CoV-2 defined variants Vasileios Papanikolaou, Aris Chrysovergis, Vasileios Ragos, Evangelos Tsiambas, Spyros Katsinis, Arezina Manoli, et al. (+7)
40 [GO] 2021―Nov―27 Understanding the role of telomere attrition and epigenetic signatures in COVID-19 severity Ata Mahmoodpoor, Sarvin Sanaie, Faranak Roudbari, Tara Sabzevari, Nasim Sohrabifar, Somayeh Kazeminasab
41 [GO] 2021―Sep―14 An overview of human proteins and genes involved in SARS-CoV-2 infection Zohreh Jahanafrooz, Zhishan Chen, Jiandong Bao, Hongzhi Li, Loren Lipworth, Xingyi Guo
42 [GO] 2021―Jul―16 Therapeutic perceptions in antisense RNA-mediated gene regulation for COVID-19 Sabrina Ferreira de Jesus, Laércio Ives Santos, João Felício Rodrigues Neto, Thallyta Maria Vieira, João Batista Mendes, Marcos Flavio Silveira Vasconcelos D'angelo, André Luiz Sena Guimaraes
43 [GO] 2021―Jul―16 No association between the SARS-CoV-2 variants and mortality rates in the Eastern Mediterranean Region Saad Omais, Samer Kharroubi, Hassan Zaraket
44 [GO] 2021―Jun―24 Variants in AGTR2 gene in Maya people with COVID-19 Armando Totomoch-Serra, Miriam Givisay Domínguez-Cruz, C. Manterola, María de Lourdes Muñoz
45 [GO] 2021―Apr―20 Inferring molecular mechanisms of dexamethasone therapy in severe COVID-19 from existing transcriptomic data Abhay Sharma
46 [GO] 2021―Mar―23 SARS-CoV-2 variants lacking ORF8 occurred in farmed mink and pangolin Filipe Pereira
47 [GO] 2021―Mar―18 Epidemiological transcriptomic data supports BCG protection in viral diseases including COVID-19 Abhay Sharma
48 [GO] 2021―Feb―15 Transmission dynamics of SARS-CoV-2 on the Diamond Princess uncovered using viral genome sequence analysis Kunikazu Hoshino, Tatsuji Maeshiro, Nao Nishida, Masaya Sugiyama, Jiro Fujita, Takashi Gojobori, Masashi Mizokami
49 [GO] 2021―Feb―11 Low serum CCL17 as a marker for severe/critical COVID-19: a pathogenic link Abhay Sharma
50 [GO] 2021―Feb―05 The use of mesenchymal stem cells in the process of treatment and tissue regeneration after recovery in patients with Covid-19 Ehsan Saburi, Mohamadfoad Abazari, Hadi Hasannia, Reyhaneh Nassiri mansour, Reza Eshaghi-Gorji, Mobina Gheibi, et al. (+2)
51 [GO] 2021―Feb―05 Mutational analysis and assessment of its impact on proteins of SARS-CoV-2 genomes from India Rezwanuzzaman Laskar, Safdar Ali
52 [GO] 2020―Dec―17 Recognition of Plausible Therapeutic Agents to Combat COVID-19: An Omics Data Based Combined Approach Mohammad Uzzal Hossain, Arittra Bhattacharjee, Md. Tabassum Hossain Emon, Zeshan Mahmud Chowdhury, Md. Golam Mosaib, Muntahi Mourin, et al. (+3)
53 [GO] 2020―Nov―28 The potential involvement of JAK-STAT signaling pathway in the COVID-19 infection assisted by ACE2 Jing Luo, Saisai Lu, Mengjiao Yu, Lixia Zhu, Chengwei Zhu, Chenlu Li, et al. (+3)
54 [GO] 2020―Nov―18 Essential functional molecules associated with SARS-CoV-2 infection: Potential therapeutic targets for COVID-19 Keshav Rajarshi, Rajni Khan, Mrityunjay K Singh, Tushar Ranjan, Sandipan Ray, Shashikant Ray
55 [GO] 2020―Sep―14 Serum CCL17 level becomes a predictive marker to distinguish between mild/moderate and severe/critical disease in patients with COVID-19 Masaya Sugiyama, Noriko Kinoshita, Satoshi Ide, Hidetoshi Nomoto, Takato Nakamoto, Sho Saito, et al. (+18)
56 [GO] 2020―Aug―31 Angiotensin-converting enzymes (ACE, ACE2) gene variants and COVID-19 outcome Juan Gómez, Guillermo M Albaiceta, Marta García-Clemente, Carlos López-Larrea, Laura Amado-Rodríguez, Inés Lopez-Alonso, et al. (+11)
57 [GO] 2020―Aug―15 Unravelling host-pathogen interactions: ceRNA network in SARS-CoV-2 infection (COVID-19) Shweta Arora, Prithvi Singh, Ravins Dohare, Rishabh Jha, Mansoor Ali Syed
58 [GO] 2020―Jul―04 SARS-CoV-2 infections and COVID-19 mortalities strongly correlate with ACE1 I/D genotype Naoki Yamamoto, Yasuo Ariumi, Nao Nishida, Rain Yamamoto, Georg Bauer, Takashi Gojobori, et al. (+2)
59 [GO] 2020―May―20 Overwhelming Mutations or SNPs of SARS-CoV-2: A Point of Caution Naveen Vankadari
 [1] 

59 Results       Page 1


[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.005 sec